Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Morgenthaler Ventures
company
About
Morgenthaler Ventures is a venture capital and private equity firm that invests in IT and life sciences companies.
- 11 - 50
Highlights
Details
- Industries
- Finance,Financial Services,Venture Capital
- Founded date
- Jan 1, 1968
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Venture Capital
Morgenthaler Ventures has been in the venture capital business for more than 45 years, steadily investing through every market cycle. Select past and present portfolio companies in the IT space include: Evernote, Lending Club, Siri, MuleSoft, Practice Fusion, Adara Media, Check, Doximity, PeopleMatter, Socrata, NuoDB, Jaspersoft, Voltage Security, Rhythm NewMedia, Nominum, Wize Commerce (NexTag) and back in the day, Apple.
Investments
Number of Investments
Number of Lead Investments
23
3
Morgenthaler Ventures has made 23 investments. Their most recent investment was on
Jun 8, 2016, when Miramar Labs raised 0.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 8, 2016
Miramar Labs
|
Series Unknown | — | Health Care | — |
|
Oct 1, 2015
Elcelyx Therapeutics
|
Series E | $40M | Biotechnology | — |
|
Oct 6, 2014
Miramar Labs
|
Series D | $26M | Health Care | — |
|
Feb 20, 2014
Elcelyx Therapeutics
|
Series C | $24.72M | Biotechnology | — |
|
Aug 13, 2012
Elcelyx Therapeutics
|
Series B | $4M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
